Science · Open for opinions
Will the FDA approve mifepristone as an official treatment for uterine fibroids in the United States by March 2027?
Recent clinical studies, including a trial in China, have shown that mifepristone reduces uterine fibroids by up to 50% and relieves… 45 opinions, 76% No
- Yes — 24%
- No — 76%
Deadline: March 22, 2027 at 12:00 AM UTC · 45 opinions
Resolution rules
Recent clinical studies, including a trial in China, have shown that mifepristone reduces uterine fibroids by up to 50% and relieves endometriosis bleeding and pain, increasing pressure for regulatory approval in the US.
Source: www.thirteen.org
Frequently asked questions about this event
How is this event resolved?
Resolução positiva se o FDA (Food and Drug Administration) publicar aprovação formal de mifepristona para indicação de fibromas uterinos em seu banco de dados oficial (drugs.fda.gov) até 22/03/2027.
How are points scored?
Points depend on the share of votes your side had when you gave your opinion. Being right earns 100 minus that share. Being wrong costs that share.
Right now No has 76% of the votes: an opinion on it that turns out right earns about 24 points, a wrong one costs about 76.